azacitidine,Magrolimab
gilead
['aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'magrolimab', 'azacitidine,(-oral azaci),(-azacitidine oral)']
oncology news update: 'eha 2022: magrolimab and azacitidine show durable responses and encouraging results in tp53-mutant aml' has been published on oncology news australia - #oncnews 
Creating Innovative Resources for the Australian Oncology Community and Beyond. Home of The Oncology Newsletter, The Oncology Podcast and https://t.co/xBVIOdvL7D